CompletedNCT03554213
Typhoid Conjugate Vaccine Introduction in Navi Mumbai, India
Studying Typhoid
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Stanford University
- Principal Investigator
- Stephen Luby, MDStanford University
- Intervention
- Typhoid Conjugate Vaccine(biological)
- Enrollment
- 17292 target
- Eligibility
- 16 years · All sexes
- Timeline
- 2018 – 2021
Study locations (6)
- D. Y. Patil Medical College and Hospital, Nerul, Navi Mumbai, India
- Dr. Joshi's Central Clinical Microbiology Laboratory, Vashi, Navi Mumbai, India
- Dr. Yewale Multispecialty Hospital for Children, Vashi, Navi Mumbai, India
- Mahatma Gandhi Memorial (MGM) New Bombay Hospital, Vashi, Navi Mumbai, India
- Mathadi Hospital Trust, Koparkharaine, Navi Mumbai, India
- Navi Mumbai Municipal Corporation (NMMC) General Hospital, First Referral Unit (FRU), Vashi, Navi Mumbai, India
Collaborators
Centers for Disease Control and Prevention · World Health Organization · National Institute of Cholera and Enteric Diseases, India · Bill and Melinda Gates Foundation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03554213 on ClinicalTrials.govOther trials for Typhoid
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT04083950Induction of Gut Permeability by an Oral VaccineUSDA, Western Human Nutrition Research Center
- ACTIVE NOT RECRUITINGPHASE3NCT03299426Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, MalawiUniversity of Maryland, Baltimore
- ACTIVE NOT RECRUITINGPHASE4NCT03970304CVD 37000: Immunity and Microbiome Studies at Intestinal and Systemic Sites in Ty21a Vaccinated AdultsUniversity of Maryland, Baltimore